InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by TOMBESI PAOLO, Chief Financial Officer. Officer active across 1 company, notably Turning Point Therapeutics, Inc.. Aggregated, 6 reports have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €87k. Activity tracked since 26 July 2021. The latest transaction was disclosed on 17 August 2022 (Disposition). Regulator: SEC (Form 4). The full history is free.
Declarations6 total
29,778 shares@ US$76.0096.2% of flowCommon StockSEC:0001209191-22-046272:0
1,183 shares@ US$74.943.8% of flowCommon StockSEC:0001209191-22-043510:0
16,283 shares0Common StockSEC:0001209191-22-008985:0
16,283 shares0Common StockSEC:0001209191-22-008985
13,600 shares0Common StockSEC:0001209191-21-048337
13,600 shares0Common StockSEC:0001209191-21-048337:0
6 of 6 declarations
About TOMBESI PAOLO
Paolo Tombesi is the Chief Financial Officer and Executive Vice President of Turning Point Therapeutics, Inc. He oversees the financial operations of the company, including budgeting and financial resource management. His expertise is essential for the success of Turning Point.
